Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus

Infection and Immunity

Volumn 65, Issue 6, 1997, Pages 2080-2087

  Ji, Yinduo ^a   Carlson, Brian ^a   Kondagunta, Aparna ^a   Cleary, P Patrick ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; GENE INSERTION; IMMUNIZATION; INTRAGASTRIC DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NASOPHARYNX; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS; WOUND INFECTION;

EID: 0030955842     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.6.2080-2087.1997     Document Type: Article

References (26)

1. Bessen, D., and V. A. Fischetti. 1988. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect. Immun. 56:2666-2672.
2. Bessen, D. E., C. M. Sotir, T. L. Readdy, and S. K. Hullingshead. 1996. Genetic correlates of throat and skin isolates of group A streptococci. J. Infect. Dis. 173:896-900.
3. Booth, S. A., C. E. Moody, M. V. Dahl, M. J. Herron, and R. D. Nelson. 1992. Dapsone suppresses integrin-mediated neutrophil adherence function. J. Investig. Dermatol. 98:135-140.
4. Bronze, M. S., H. S. Courtney, and J. B. Dale. 1992. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses. J. Immunol. 148:888-893.
5. Chen, C., and P. Cleary. 1990. Complete nucleotide sequence of the streptococcal C5a pcptidase gene of Streptococcus pyogenes. J. Biol. Chem. 265:3161-3167.
6. Chmouryguina, I., A. Suvorov, P. Ferrieri, and P. Cleary. 1996. Conservation of the C5a peptidase genes in group A and B streptococci. Infect. Immun. 64:2387-2390.
7. Cleary, P., E. D. Chenoweth, and D. Wexler. 1985. A streptococcal inactivator of chemotaxis: a new virulence factor specific to group A streptococci, p. 179. In Y. Kimura. S. Kotami, and Y. Shiokawa (ed.), Recent advances in streptococci and streptococcal diseases. Reedhooks Ltd., Windsor. England.
8. Cleary, P., J. Handley, A. Suvorov, A. Podbielski, and P. Ferrieri. 1992. Similarity between the group B and A streptococcal C5a peptidasc genes. Infect. Immun. 60:4239-4244.
9. Cleary, P., U. Prahbu. J. B. Dale, D. E. Wexler, and J. Handley. 1992. Streptococcal C5a peptidase is a highly specific endopeptidase. Infect. Immun. 60:5219-5223.
10. Courtney, H., M. S. Bronze, J. B. Dale, and D. L. Hasty. 1994. Analysis of the role of M24 protein in group A streptococcal adhesion and colonization by use of omega-interposon mutagenesis. Infect. Immun. 62:4868-4873.
11. Cunningham, M. W., N. K. Hall, K. K. Krisher, and A. M. Spanier. 1986. A study of anti-group A streptococcal monoclonal antibody cross reactive with myosin. J. Immunol. 136:293-298.
12. Fischetti, V. A. 1989. Streptococcal M protein: molecular design and biological behavior. Clin. Microbiol. Rev. 2:285-314.
13. Gemmell, C. G., P. K. Peterson, W. Regelman, D. Schmeling, J. R. Hoidal, and P. G. Quie. 1981. Phagocytosis and killing of Streptococcus pyogenes by human alveolar macrophages. Infect. Immun. 32:1298-1300.
14. Haanes, E. J., D. G. Heath, and P. P. Cleary. 1992. Architecture of the vir regulons of group A streptococci parallels opacity factor phenotype and M protein class. J. Bacteriol. 174:4967-4976.
15. Hollingshead, S. K., T. L. Readdy, D. L. Yung, and D. Bessen. 1993. Structural heterogeneity of the emm gene cluster in group A streptococci. Mol. Microbiol. 8:707-717.
16. Hollingshead, S. K., J. W. Simecka, and S. M. Michalek. 1993. Role of M protein in pharyngeal colonization by group A streptococci in rats. Infect. Immun. 61:2277-2283.
17. Ivey, C. L., F. M. Williams, and P. Collins. 1995. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. J. Clin. Invest. 95:2720-2728.
18. Ji, Y., L. McLandsborough, A. Kondagunta, and P. P. Cleary. 1996. C5a peptidase alters clearance and trafficking of group A streptococcus by infected mice. Infect. Immun. 64:503-510.
19. Lancefield, R. C. 1957. Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to bactericidal test. J. Exp. Med. 106:525-685.
20. O'Connor, S. P., D. Darip, K. Fraley, C. Nelson, E. L. Kaplan, and P. Cleary. 1990. The human antibody response to streptococcal C5a peptidase. J. Infect. Dis. 163:109-116.
21. Podblelski, A., A. Flosdorff, and J. Weber-Heynemann. 1995. The group A streptococcal virR49 gene controls expression of four structural vir regulon genes. Infect. Immun. 63:9-20.
22. Podblelski, A., N. Schnitzler, P. Beyhs, and D. P. Boyle. 1996. M-relatcd protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes. Mol. Microbiol. 19:429-441.
23. Simpson, W. J., D. LaPenta, C. Chen, and P. Cleary. 1990. Coregulation of type 12 M protein and streptococcal C5a peptidase genes in group A streptococci: evidence for a virulence regulon controlled by the virR locus. J. Bacteriol. 172:696-700.
24. Raeder, R., and M. D. P. Boyle. 1996. Properties of IgG-binding proteins expressed by Streptococcus pyogenes isolates are predictive of invasive potential. J. Infect. Dis. 173:888-895.
25. Wessels. M. R., J. B. Goldberg, A. E. Moses, and T. J. DiCesare. 1993. Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infect. Immun. 62:433-441.
26. Wexler, D. E., E. D. Chenoweth, and P. Cleary. 1985. Mechanism of action of the group A streptococcal C5a inactivator. Proc. Natl. Acad. Sci. USA 82:8144-8148.